Release time: November 8, 2024 | Information source: Iger Capital

Shenbi Biotech successfully completed the delivery of a tens of millions of angel+ rounds of financing. This round of financing was exclusively supplemented by Meihua Venture Capital. This good news marks a solid step taken by Shenbi Biotech on its development path, and also demonstrates the capital market's firm confidence in its innovation capabilities and development potential.

ScreenShot_2026-01-12_155405_172.png

Shenbi Biotechnology focuses on the field of biotechnology and is committed to using innovative biotechnology to solve key problems in the agricultural field. Its core technologies cover many cutting-edge fields such as biosynthesis and gene editing. By applying these advanced technologies to agricultural production, it has developed a series of innovative and high value-added products and solutions.

Shenbi Biotech attaches great importance to industry-university-research cooperation and has established close cooperative relationships with many well-known universities and scientific research institutions. By integrating resources from all parties, the rapid transformation of scientific and technological achievements has been achieved, and the core competitiveness of the enterprise has been continuously improved. The company has an internal R&D team composed of senior experts and professional technicians. They have rich industry experience and excellent innovation capabilities, providing solid talent support for product R&D and technology upgrades.

As the capital party of this exclusive additional investment, Plum Blossom Venture Capital has made outstanding achievements in the investment field. His investment style is unique, focusing on finding innovative and high-growth early-stage projects, especially in the field of technology, with keen insight and rich investment experience.

After completing this financing, Shenbi Biotech is expected to achieve breakthroughs in many aspects. On the one hand, enterprises will further increase investment in research and development, accelerate the research and development of new products and technological innovation, continuously enrich and improve product systems, and enhance product performance and market competitiveness. On the other hand, enterprises will strengthen marketing and brand building, expand sales channels, expand market share, and improve brand awareness and reputation. In addition, Shenbi Bio will also actively seek cooperation opportunities with upstream and downstream enterprises, integrate industry chain resources, and achieve coordinated development. From the perspective of investment return, as Shenbi Biotech expands its market share, improves profitability, and strengthens industry influence, investors are expected to receive generous returns, including equity appreciation, dividend income, etc. At the same time, investing in Shenbi Biotech can not only obtain economic returns, but also make positive contributions to social welfare undertakings such as promoting green agricultural development, ensuring food safety, and promoting environmental protection.

Tags
Share

Related information

Start your business project?

Contact us
CTA